Present

25-27 May 2027

Hamburg, Germany

Showcase your research to the global lab automation and life sciences community in Hamburg!

Present

Opportunities to Present at SLAS Europe 2027

SLAS invites research scientists, engineers, academics and business leaders to submit abstracts for presentation in any one of the three educational tracks featured at this year's conference. Contributions from graduate students, post-doctoral associates and junior faculty are encouraged. Abstract submissions from academia, government and industry are also welcome.

Learn more about this year's three educational tracks: Advances in Drug Discovery, Advances in Laboratory Automation and Screening Applications & Diagnostics.

Submit an Abstract

Important Deadlines

Podium Abstract Submissions Due:

Monday, 25 January 2027

SLAS Travel Award Podium Submissions Due:

Monday, 25 January 2027

SLAS Travel Award Poster Submissions Due:

Monday, 8 February 2027

Student Poster Award Abstract Submissions Due:

Monday, 8 February 2027

Priority Poster Submission Deadline:

Monday, 29 March 2027

Regular (Non-Award) Poster Submission Deadline:

Monday, 3 May 2027

SLAS Europe 2027 Educational Tracks

This year, the SLAS Europe 2027 scientific program will feature three educational tracks:

Advances in Drug Discovery
Advances in Laboratory Automation
Screening Applications & Diagnostics

Visit the Learn section for detailed descriptions of each track and its scientific sessions and panel discussions.

Award Opportunities

SLAS Travel Award Program

The SLAS Travel Award Program includes airfare or mileage reimbursement, full conference registration and hotel accommodations. Students, graduate students, postdoctoral associates and junior faculty are encouraged to apply.

Learn More

Student Poster Award

The SLAS Student Poster Award recognizes innovative research by students, graduate students, post-doctoral associates and junior faculty (less than four years in their first academic appointment) who are chosen to present a poster during SLAS Europe 2027.

Learn More

SLAS Europe 2027 Abstract Submission Requirements

To simplify your submission process, please have all of your materials together prior to entering your abstract. You will be able to view screenshots of each step in the abstract process by using the 'Guidelines' section of the submission site.

You will be asked to answer AI Usage Questions as part of the abstract submission process. These questions are neither qualifying nor disqualifying and will not be used in the review process. These questions are for informational purposes only, to help the program committee determine whether AI is part of the research plan, whether generative AI was used to write the abstract, and/or whether AI will be used to generate content for the talk.

To submit, you will need the following:

Abstract title
Abstract text (450-word limit)

Please include the following information in your abstract:

Purpose of the study
Description of experimental procedures
Summary of data
Conclusion statement
Next steps and future experiments
Any information regarding potential travel restrictions and/or approval permissions that could impact your ability to participate in SLAS Europe 2027

Abstracts should be carefully proofread to avoid errors in the published literature. American spelling should be used throughout; for more information regarding American spelling, please refer to Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, Eighth Edition (Council of Science Editors, 2014).

Presentation preference: podium, poster or both (if applicable)
Identify applicable track (preference only)
Primary presenter details (one per abstract); Name, Job Title, Organization, Address, City, State, Postal Code, Country, Email, Business Phone, Biography
Award nominations (if applicable)
Identify co-authors: Name, Job Title, Organization, City, State, Country, Email

Abstracts relevant to any of the SLAS Europe 2027 tracks are requested and will be reviewed by the SLAS Europe 2027 Scientific Program Committee.

Authors are invited to submit abstracts describing original research on topics relevant to any of the seven program tracks for either poster or podium presentation. Abstracts should describe work not previously the subject of a podium presentation and address why the work is novel. The abstract should clearly present the research itself and the results that have been obtained. Abstracts will be assessed according to the novelty of the work, with an emphasis on abstracts that clearly detail results.

Podium presentations are 25 minutes in length, including questions and answers.

Poster presentations are scheduled for a 1-hour time slot as noted on the Poster Presentation Guidelines webpage.

The primary presenter will serve as the primary contact for SLAS and must have a valid email address.
All abstracts must be submitted electronically via this online abstract submission system.
The body of the abstract may not exceed 450 words.
The title is considered separate from the body of the abstract and is not included in the word limit. Specific formatting requirements are included on the submission form.
It is suggested that you first develop your abstract in a word processing program, then copy and paste the information into the appropriate section. There is no spell or grammar check function in the online submission process. Please do not use all capital letters in your abstract or title.
If accepted, your abstract will be published EXACTLY as it has been entered into the system. This includes company names, presenter names, etc. Submissions will not be edited in any way prior to publishing in conference materials.
Fields denoted with asterisks (*) are required fields.
To learn more about the various SLAS Awards presented at the conference and learn if you are eligible to apply, please visit the following links:
- SLAS Travel Awards
- SLAS Student Poster Award
At the close of the applicable submission period, all abstracts will be reviewed by the SLAS Europe 2027 Scientific Program Committee to determine which abstracts are accepted into the program. The SLAS Europe 2027 Scientific Program Committee reserves the right to accept abstracts into tracks other than the one selected by the submitter during the submission process.
Those submitted as podium abstracts but not accepted for the podium program will be reviewed for a poster submission if indicated as such by the submitter during the submission process.
Podium presentation confirmations will be distributed in mid-February 2027.

Abstract Acceptance and Notification

A member of the SLAS Professional Team will contact all selected abstract submitters with information regarding scheduling, speaker agreements, and the Speaker Resource Center. Speakers agree to use the Speaker Resource Center as the primary source for communicating speaker information.

It is expected that all speakers will adhere to the policies and deadlines established to ensure the accurate and timely dissemination of information to SLAS conference attendees.

Primary presenters are responsible for communicating with co-authors regarding acceptance or rejection, deadlines and all other submission details.

Whenever possible, SLAS will record presentations and make those recordings available to members and participants. In some cases, webcasting or streaming of sessions may also be offered. All speakers will be required to provide SLAS with the permission to record, broadcast, edit, transcribe, archive, duplicate, distribute, reproduce and sell any written or visual material submitted in connection with presentations at this SLAS conference in any media now existing or developed in the future.

SLAS presenters are required to electronically agree to the speaker guidelines and releases using the button below.

Accepted poster presentations will be required to physically present their posters during a two-hour time slot, as indicated in the acceptance notification.

Presentation confirmations will be distributed according to the approximate timeline below:
- Podium Presentation Confirmation: February 2027
- Travel Award Application Confirmations: March 2027
- Poster Presentation Confirmations: Beginning March 2027

Speaker’s Agreement

Selected speakers must agree to the following:

I desire to make a presentation (“Presentation”) at the Society for Laboratory Automation and Screening’s (“SLAS”) SLAS Europe 2027, 25-27 May (“Event”). In exchange for being permitted to make my Presentation at the Event and the benefits derived from my Event participation, as well as other good and valuable consideration, I hereby knowingly and voluntarily execute this Speaker Agreement (“Agreement”):

LOGISTICS. I shall provide my Presentation live and in person at the Event on the dates, at the times, and at the location specified by SLAS.

MATERIALS. In connection with my Presentation, I shall provide SLAS with my presentation slides according to SLAS specifications, photograph, biographical information, and Presentation abstract (“Materials”) by the date, in the format, and in the manner specified by SLAS. I hereby grant SLAS a worldwide, sub-licensable, perpetual, irrevocable, non-exclusive, royalty-free right and license (but not the obligation) to reproduce, prepare derivative works based on, distribute, perform publicly, display publicly, and otherwise use and exploit my Materials, for all purposes, including advertising, trade, and commercial purposes, in all media now known or hereafter created, in connection with: (i) promoting the Event and my Presentation (ii) SLAS’s online learning management system; and (iii) reporting on the Event.

PUBLICITY RELEASE. I hereby knowingly, voluntarily, and irrevocably consent to any and all duplications, composite or modified representations, transmissions, distributions, making available to the general public, public performances, public displays, and other uses of any kind throughout the world, by SLAS or its designees, of my name, photograph, image, likeness, voice, biographical information, other identifiable attributes, and digital replicas (defined below), in all formats and media now known or hereafter created, including composite or modified representations, for all purposes, including advertising, trade, and other commercial purposes, in all media now known or hereafter created, in connection with: (i) the Event and my Presentation; (ii) SLAS’s online learning management system; (iii) promoting future SLAS events; and (iv) reporting on the Event (“Permitted Use”). Despite the foregoing, SLAS is not entitled to create Digital Replicas (defined below) of my voice, image, or likeness without my prior written permission. For purpose of this Agreement, “digital replicas” means a newly created, electronic representation of my voice, image, or likeness created using a computer, algorithm, software, tool, artificial intelligence, or other technology that is fixed in a sound recording or audiovisual work in which I did not actually perform or appear, and which a reasonable person would believe is my voice, image, or likeness being imitated. I hereby forever releases SLAS and its directors, officers, employees, VOLUNTEERS, CONTRACTORs, and agents from any and all claims, actions, damages, losses, costs, expenses, and liability of any kind, arising under any legal or equitable theory whatsoever at any IN connection with any Permitted Use.

RECORDINGS. I hereby grant SLAS a worldwide, sub-licensable, perpetual, irrevocable, exclusive, royalty-free right and license (but not the obligation) to photograph, record and film, in film, audio-video, audio-only, or any other media now known or hereafter created, me and my Presentation at the Event (“Recordings”). SLAS is the exclusive owner of the Recordings and has the exclusive right to reproduce, prepare derivative works based on, distribute, perform publicly, display publicly, transfer, license, and otherwise use and exploit the Recordings. Despite the foregoing, SLAS shall not include SLAS’s recording of my entire Presentation in SLAS’s online learning management system (which allows members of the public to access and view the recording of my Presentation) without my written permission.

RETAINED RIGHTS. I hereby retain all rights in my Presentation, my Materials, and my name, photograph, image, likeness, and voice not licensed to SLAS under this Agreement, including my underlying ownership of my Presentation and my Materials.

INSPECTION AND APPROVAL WAIVER. I hereby waive any right to inspect or approve any use of my Materials, the Recordings, and my name, photograph, image, likeness, and voice, by SLAS, contemplated by this Agreement.

NO FINANCIAL COMPENSATION. Except as otherwise stated in the speaker resource center honorarium statement, I am not entitled to receive any financial compensation as consideration for this Agreement or the rights or consents granted to SLAS hereunder. I have no right to share in any proceeds enjoyed by SLAS, derived from SLAS’s exploitation of the rights granted to SLAS under this Agreement.

REPRESENTATIONS AND WARRANTIES. In addition to any other representations and warranties made by me in this Agreement, I represent and warrant that: (i) I am over the age of 18; (ii) I have all of the legal rights necessary to enter into, perform my obligations under, and grant SLAS the rights stated in this Agreement; (iii) my entering into, performing my obligations under, and granting SLAS the rights stated in this Agreement does not violate applicable law or the rights of any third-party; (iv) my Presentation and Materials will not promote specific goods, services, commercial interests, or my personal business or financial interests; (v) my Presentation and Materials will not contain profanity or content that is defamatory, abusive, harassing, violent, or hateful; (vi) my Presentation and Materials will not denigrate or promote discrimination against any individual or groups of individuals based on their race, color, religion, creed, national origin, ancestry, ethnicity, sex, gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, military status, or political affiliation; and (vii) I shall comply with all Event venue’s and SLAS’s policies, procedures, rules, guidelines, and directions applicable to my Event participation, Presentation, and Materials. I agree to defend, indemnify, and hold harmless SLAS and its directors, officers, employees, volunteers, agents, representatives, contractors, and affiliates from and against all claims by third parties relating to my breach or alleged breach of this Agreement, including or any of the foregoing representations and warranties.

CANCELLATION. SLAS is entitled to cancel my Presentation and Event participation at any time by notifying me of its decision to do so. If I am unable to provide my Presentation at the Event for any reason, I shall notify SLAS as soon as possible.

WAIVER OF CLAIMS AND LIMITATION OF LIABILITY. To the fullest extent permitted by applicable law, I hereby irrevocably waive all legal and equitable rights relating to all liabilities, claims, demands, actions, suits, damages, and expenses of any kind, including claims for copyright or trademark infringement, defamation, invasion of any rights of privacy, violation of rights of publicity, physical or emotional injury or distress, or any similar claims or causes of action in tort, contract, equity, or any other legal theory, now known or hereafter known in any jurisdiction throughout the world (“Claims”), I may have directly or indirectly against SLAS and any of its directors, officers, employees, volunteers, agents, representatives, contractors, and affiliates (collectively, “Released Persons”) related to: (i) my Event participation, Presentation, Materials, name, photograph, image, likeness, and voice; (ii) the Recordings; and/or (iii) SLAS’s use and exploitation of the rights granted to SLAS under this Agreement. I covenant not to make or bring any Claims against SLAS and the other Released Persons and forever release and Discharge SLAS and the other Released Person from liability under all Claims.

RELATIONSHIP OF THE PARTIES. This Agreement creates an independent contractor relationship between me and SLAS. This Agreement does not create any other kind of legal relationship between me and SLAS. I am not entitled to contract for or bind SLAS.

GOVERNING LAW, CHOICE OF FORUM, JURY TRIAL WAIVER. The laws of the State of Illinois, excluding its choice of law rules, govern this Agreement and the federal laws of the United States. A party shall institute any action related to this Agreement in the United States District Court for the Northern District of Illinois, or the Illinois state courts located in DuPage County, Illinois. The parties irrevocably submit to the exclusive jurisdiction of these courts. Each party hereby waives, to the extent permitted by applicable Law, any right to a trial by jury, in any action between the parties related to this Agreement.

MISCELLANEOUS. This Agreement inures to the benefit of, and is binding on, the parties and their heirs, executors, administrators, legal representatives, successors, and permitted assigns. If there is a conflict between the headings or section numbers and the text of this Agreement, the text controls. No inference, presumption, or conclusion is to be drawn against a party because that party, or its directors, officers, employees, volunteers, agents, representatives, contractors, or affiliates drafted all or any part of this Agreement. If a court having jurisdiction over a dispute between the parties, determines any portion of this Agreement is unenforceable, the rest of this Agreement remains in effect to the extent permitted by applicable law. Upon a determination that any portion of this Agreement is unenforceable, it is the desire of the parties that the court modify this Agreement to effect the original intent of the parties as closely as possible in order that the transaction contemplated by this Agreement may be consummated as originally contemplated to the greatest extent possible under applicable law. Provisions in this Agreement, which, by their nature, should apply beyond the termination or conclusion of this Agreement, remain in force after this Agreement’s termination or conclusion. No amendment to this Agreement is valid unless in writing and signed by both parties.

ENTIRE AGREEMENT. This Agreement states the entire agreement between the parties regarding the subject matter of this Agreement, and supersedes all prior negotiations, understandings, and agreements (oral or written) between the parties, regarding the subject matter of this Agreement.

Privacy Notice (non-European Union or non-United Kingdom Residents)
Privacy Notice (EU/UK/Switzerland Residents)

All presenters must be registered as full conference participants. Limited funds may be available to assist with travel and/or hotel funding. These funds are based on availability and financial need. Contact Stephanie Salerno at ssalerno@slas.org for more information.

All poster presenters must be registered as full conference attendees, unless they are also registered as SLAS exhibitors.